International Clinical Trial: Clinical Study on the Safety and Relationship of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07127497) titled 'Clinical Study on the Safety and Relationship of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma' on Aug. 11.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: The First Affiliated Hospital of Anhui Medical University

Condition: Objective Response Rate for Neoadjuvant Chemotherapy, ORR

Intervention: Biological: Sintilimab combined with XELOX

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: June 1, 20...